AlanHMarkowitzMD
Thoracic Surgery • Cleveland, OHAdult Cardiac Surgery, Cardiovascular Surgery
Fulltime University practice; Chair, Valvular Heart Dis; Chief Surg Officer Heart-Vascular Inst
Dr. Markowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-5770Fax+1 216-844-1202
Summary
- Principal investigator in 8 clinical trials regarding valvular heart disease and heart failure.
Clinical Expertise
- Tricuspid valve repair, Aortic surgery, Echocardiogram, Cardiopulmonary bypass, Coronary artery bypass grafting, Mitral valve surgery, Congenital aortic stenosis, Valvular disease, Maze surgery, Reoperative cardiac surgery, Valvular heart disease; alternative perfusion strategies; stroke avoidance; percutaneous valve implantation
Education & Training
Weatherhead School of Managementprof fellow, Hosp admn, 1993 - 1994
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Thoracic Surgery, 1976 - 1978- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1970 - 1976
- US NavyMilitary service, Battalion physician, 1972 - 1974
Albany Medical CollegeClass of 1970
Certifications & Licensure
OH State Medical License 1974 - 2026- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Alan Markowitz Chair in Cardiac and Vascular Syrgery University Hispitals Cleveland Medical Center, 2019
- Physician of the Year University Hospitals 1866 Society, 2015
- Dolly Haugh Chair in Valvular Heart Surgery University Hospitals, 2008
- Join now to see all
Clinical Trials
- Anesthesia Charting Fidelity Study Start of enrollment: 2010 Aug 01
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Midterm Survival, Clinical, and Hemodynamic Outcomes of a Novel Mechanical Mitral Valve Prosthesis.Marc Ruel, Michael W A Chu, Allen Graeve, Marc W Gerdisch, Ralph J Damiano Jr
The Journal of Thoracic and Cardiovascular Surgery. 2024-11-29 - 1 citationsImpact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis.Saki Ito, Roger Laham, Vuyisile T Nkomo, John K Forrest, Michael J Reardon
Open Heart. 2023-05-01 - 7 citationsLow-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial.Michael W A Chu, Marc Ruel, Allen Graeve, Marc W Gerdisch, Ralph J Damiano Jr
The Annals of Thoracic Surgery. 2023-04-01
Press Mentions
UH Cleveland Medical Center Expanding Aortic Valve Replacement Procedure to Low-Risk PatientsDecember 19th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
